欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
VERU-111_1332881-26-1_产品详情
1332881-26-1
  • names:

    VERU-111

  • CAS号:

    1332881-26-1

    MDL Number:
  • MF(分子式): C21H19N3O4 MW(分子量): 377.39
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
VERU-111
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM002561-250mg 250mg ¥ 0.00 ¥ 0.00 Backorder
- +
¥ 0.00
YZM002561-100mg 100mg >97% ¥ 0.00 ¥ 0.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 1332881-26-1
Inchi
InchiKey
分子式 Formula C21H19N3O4
分子量 Molecular Weight 377.39
溶解度Solubility
性状
储藏条件 Storage conditions 请根据产品建议的存储条件进行存储,Please store the product under the recommended condition sin the description.
VERU-111(CAS:1332881-26-1)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 VERU-111 (ABI-231) 是一种有效的高效、口服可利用 α/β 微管蛋白(tubulin)抑制剂,具有很强的抗增殖活性,对黑素瘤和前列腺癌细胞系作用的平均 IC50值为 5.2 nM
IntroductionVERU11 (ABI31) is a potent and orally bioavailableα and β tubulininhibitor, which displays strong antiproliferative activity, with an average IC50of 5.2 nM against panels of melanoma and prostate cancer cell lines. VERU11 (ABI31) suppresses tumor growth and metastatic phenotypes of cervical cancer cells via targeting HPV E6 and E7, and has potential for the treatment of prostate cancer[2][3].
Application1
Application2
Application3
VERU-111 (ABI-231) 是一种有效的高效、口服可利用 α/β 微管蛋白(tubulin)抑制剂,具有很强的抗增殖活性,对黑素瘤和前列腺癌细胞系作用的平均 IC50值为 5.2 nM。VERU-111 (ABI-231) 通过靶向 HPV E6 和 E7 抑制肿瘤生长和转移表型,还具有治疗前列腺癌的潜力。VERU-111 (ABI-231) is a potent and orally bioavailableα and β tubulininhibitor, which displays strong antiproliferative activity, with an average IC50of 5.2 nM against panels of melanoma and prostate cancer cell lines. VERU-111 (ABI-231) suppresses tumor growth and metastatic phenotypes of cervical cancer cells via targeting HPV E6 and E7, and has potential for the treatment of prostate cancer[1][2][3].
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Wang Q, et al. Structure-Guided Design, Synthesis, and Biological Evaluation of (2-(1H-Indol-3-yl)-1H-imidazol-4-yl)(3,4,5-trimethoxyphenyl) Methanone (ABI-231) Analogues Targeting the Colchicine Binding Site in Tubulin. J Med Chem. 2019 Jul 12.
【2】.Qinghui Wang, et al. Discovery of ABI-231 analogs targeting the colchicine site in tubulin for advanced melanoma. Cancer Research 76(14 Supplement):4848-4848.
【3】.Vivek Kashyap, et al. ABI-231: A novel small molecule suppresses tumor growth and metastatic phenotypes of cervical cancer cells via targeting Human papilloma virus (HPV) E6 and E7. Cancer Research 78(13 Supplement):679-679.
【4】.Kashyap VK, et al. Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer. J Exp Clin Cancer Res. 2019 Jan 23;38(1):29.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents